(EMAILWIRE.COM, September 06, 2018 ) Monoclonal antibodies are highly specific to cancer cells as they bind to the proteins on their surface and stimulate an immune response. Monoclonal Antibodies (mAbs) are mono-specific antibodies bodies comprising of identical immune cells that are clones of a single parent cells and are directed to a specific cellular targets. These antibodies are highly customizable as it is specific in nature and also play a vital role in eliminating the cancerous cell during the cancer treatment. Thus monoclonal antibodies are proved to be more effective when compared to chemotherapy or other cancer treatment.

Request Report Sample: https://www.marketdataforecast.com/market-reports/global-monoclonal-antibodies-market-1184/request-sample

Factors affecting market growth:
• Increasing R&D activities in genomics studies. (+)
• Rising advancements of technologies in genetic platforms. (+)
• Growing awareness about various mAb applications among global population and physicians. (+)
• Increasing demand for monoclonal antibodies. (+)
• Rising prevalence of cancer and other chronic diseases. (+)
• Huge investments for conducting R&D activities. (-)
• High cost for monoclonal antibodies treatment. (-)

Get your customized report: https://www.marketdataforecast.com/market-reports/global-monoclonal-antibodies-market-1184/customize-report

Market Segmentation
The Global Monoclonal Antibodies Market is geographically segmented into
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa
North America holds the largest market share for monoclonal antibodies market due to presence of well-established healthcare facilities, the rise in demand for advanced healthcare systems and growing awareness regarding cancer treatments in this region.

Asia-Pacific is rapidly growing in monoclonal antibodies market due to healthcare expenditures, increase in number of cancer patients, and improving healthcare facilities which expected to record a high growth rate during the forecast period.

Browse full Table of Contents: https://www.marketdataforecast.com/press-releases/global-monoclonal-antibodies-market-1189/

Key players:
Leading companies in the Global Monoclonal Antibodies Market are Seattle Genetics (U.S.), Bristol-Myers Squibb (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Teva Pharmaceutical Industries Ltd. (Israel) and Shanghai Junshi Bioscience Co.,Ltd. (China), GlaxoSmithKline plc (U.K.), Novartis AG (Switzerland), Pfizer Inc. (U.S.), (U.S.), Eli Lilly and Company (U.S.), and Thermo Fisher Scientific Inc.

Contact Info:
Name: Mr. Abhishek Shukla
Email: abhishek@marketdataforecast.com
Organization: MarketDataForecast™
Address: 2nd Floor, Above ICICI Bank,B-44, Rd Number 3, Journalist Colony, Film Nagar, Hyderabad, Telangana 500033, India.
Phone: +1-888-702-9626

Contact Information:
Market Data Forecast.
Abhishek Shukla
Tel: +1-888-702-9626
Email us


----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results